Login / Signup

Insights into the role of JAK2-I724T variant in myeloproliferative neoplasms from a unique cohort of New Zealand patients.

Christopher Puli'uveaTracey ImmanuelTaryn N GreenPeter TsaiPeter R ShepherdMaggie L Kalev-Zylinska
Published in: Hematology (Amsterdam, Netherlands) (2024)
-I724T variant does not drive MPN, but additional investigations are required to exclude any potential modulatory effect on the MPN phenotype.
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • peritoneal dialysis
  • prognostic factors
  • patient reported
  • human health